Cormedix Therapeutics To Participate In Two Upcoming Investor Conferences

2026-05-15 08:31:43

(MENAFN- GlobeNewsWire - Nasdaq) PARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that management will be participating in fireside chats and investor meetings at both the RBC Capital Markets Global Healthcare Conference being held in New York on May 19 – 20, 2026 and the Jefferies Global Healthcare Conference being held in New York on June 2 – 4, 2026. Details for each fireside chat is as follows:

RBC Capital Markets Global Healthcare Conference
Date:	Wednesday, May 20, 2026
Time:	11:00am EDT
Webcast:	Click here

Jefferies Global Healthcare Conference
Date:	Wednesday, June 3, 2026
Time:	4:20pm EDT
Webcast:	Click here

About CorMedix

CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases in the United States. CorMedix is focused on selling and marketing products in institutional settings of care in the US and has field based medical and commercial infrastructure deployed in hospitals, clinics and infusion centers. For more information visit:

Investor Contact:
Dan Ferry
Managing Director
LifeSci Advisors
...
(617) 430-7576

MENAFN15052026004107003653ID1111121075

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.